Lanosterol biosynthesis pathway in GtoPdb v.2023.1
DOI:
https://doi.org/10.2218/gtopdb/F104/2023.1Abstract
Lanosterol is a precursor for cholesterol, which is synthesized primarily in the liver in a pathway often described as the mevalonate or HMG-CoA reductase pathway. The first two steps (formation of acetoacetyl CoA and the mitochondrial generation of (S)-3-hydroxy-3-methylglutaryl-CoA) are also associated with oxidation of fatty acids.
Downloads
Downloads
Published
26-Apr-2023
Issue
Section
Summaries
How to Cite
“Lanosterol biosynthesis pathway in GtoPdb v.2023.1” (2023) IUPHAR/BPS Guide to Pharmacology CITE, 2023(1). doi:10.2218/gtopdb/F104/2023.1.